北京商报讯（记者 丁宁）11月10日早间，深交所公告，创业慧康（300451）拟披露重大事项，根据深 交所《创业板股票上市规则》的有关规定，经公司申请，公司股票于11月10日开市起停牌，待公司通过 指定媒体披露相关公告后复牌。 交易行情显示，11月7日，创业慧康收涨7.02%，收盘价为5.18元/股，全天成交金额为6.74亿元，出现明 显放量。 ...

北京商报讯（记者 丁宁）11月10日早间，深交所公告，创业慧康（300451）拟披露重大事项，根据深 交所《创业板股票上市规则》的有关规定，经公司申请，公司股票于11月10日开市起停牌，待公司通过 指定媒体披露相关公告后复牌。 针对公司相关问题，北京商报记者致电创业慧康董秘办公室，公司相关负责人表示，"不清楚停牌原 因，等中午发公告。" ...

Core Viewpoint - The company, Chuangye Huikang Technology Co., Ltd., is set to disclose significant matters, leading to a temporary suspension of its stock trading on the Shenzhen Stock Exchange starting November 10, 2025 [1] Group 1 - The company has applied for a trading suspension in accordance with the relevant regulations of the Shenzhen Stock Exchange's listing rules for the Growth Enterprise Market [1] - The stock trading will resume after the company discloses the relevant announcement through designated media [1]

Core Viewpoint - The company Chuangye Huikang Technology Co., Ltd. is set to disclose significant matters, leading to a suspension of its stock trading starting November 10, 2025, until further announcements are made through designated media [1]. Group 1 - The stock of Chuangye Huikang will be suspended from trading on November 10, 2025 [1]. - The resumption of trading will depend on the company’s disclosure of relevant announcements [1].

Group 1 - The company Chuangye Huikang Technology Co., Ltd. (stock code: 300451) is set to disclose significant matters [1] - The company's stock will be suspended from trading starting November 10, 2025, until further announcements are made through designated media [1]

Market Overview - On November 7, the AI medical sector declined by 0.83%, with Madi Technology leading the drop [1] - The Shanghai Composite Index closed at 3997.56, down 0.25%, while the Shenzhen Component Index closed at 13404.06, down 0.36% [1] Stock Performance - Notable gainers included: - Chuangyi Huikang (300451) with a closing price of 5.18, up 7.02% on a trading volume of 1.3279 million shares and a turnover of 674 million yuan [1] - Other stocks showed minor fluctuations, with some experiencing slight declines: - Madi Technology (603990) closed at 16.98, down 4.12% with a trading volume of 257,500 shares and a turnover of 442 million yuan [2] Capital Flow - The AI medical sector saw a net outflow of 476 million yuan from institutional investors, while retail investors contributed a net inflow of 304 million yuan [2] - The capital flow for individual stocks indicated varied investor sentiment, with some stocks experiencing significant net inflows from retail investors despite overall sector declines [3]

Core Insights - The stock price of Chuangye Huikang increased by 2.07% on November 4, reaching 4.94 CNY per share, with a total market capitalization of 7.653 billion CNY [1] - The company has experienced a year-to-date stock price increase of 10.27%, with a recent 5-day increase of 5.33% [1] Company Overview - Chuangye Huikang Technology Co., Ltd. was established on December 10, 1997, and went public on May 14, 2015. The company is based in Hangzhou, Zhejiang Province [2] - The main business involves information technology services in the healthcare sector, including software applications, system integration, and environmental monitoring services [2] - Revenue composition includes: technical services (44.95%), software sales (44.48%), system integration (9.59%), and others (0.98%) [2] Financial Performance - For the period from January to September 2025, Chuangye Huikang reported revenue of 862 million CNY, a year-on-year decrease of 26.26%, and a net profit attributable to shareholders of -122 million CNY, a decrease of 331.69% [2] - The company has distributed a total of 230 million CNY in dividends since its A-share listing, with 30.9355 million CNY distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 0.69% to 64,400, with an average of 23,711 circulating shares per person, an increase of 0.70% [2] - Notable changes in institutional holdings include a reduction in shares held by major shareholders such as Nuoan Active Return Mixed A and Southern CSI 1000 ETF [3]

二、持有人会议审议情况 证券代码：300451 证券简称：创业慧康 公告编号：2025-066 创业慧康科技股份有限公司 2025 年员工持股计划第一次持有人会议决议公告 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、持有人会议召开情况 创业慧康科技股份有限公司（以下简称"公司"或"创业慧康"）2025 年员工持 股计划（以下简称"本持股计划"）第一次持有人会议于 2025 年 11 月 3 日在公司 会议室以现场结合通讯的方式召开，出席本次会议的持有人共计 28 人，代表本 持股计划份额 12,262,302 份，占本持股计划总份额的 100%。本次会议由公司董 事会秘书胡燕女士召集和主持，本次会议的召开符合《创业慧康科技股份有限公 司 2025 年员工持股计划（草案）》《创业慧康科技股份有限公司 2025 年员工持 股计划管理办法》及相关法律、法规、规范性文件的规定，会议决议合法、有效。 （一）审议通过了《关于设立 2025 年员工持股计划管理委员会的议案》 为保证 2025 年员工持股计划的顺利进行，保障持有人的合法权益，根据《创 业慧康科技股份有限公 ...

Core Viewpoint - Chuangye Huikang Technology Co., Ltd. is a leading enterprise in the domestic healthcare information technology sector, focusing on software and system integration for healthcare informationization, with a full industry chain service capability [1] Group 1: Business Performance - In Q3 2025, Chuangye Huikang achieved a revenue of 862 million yuan, ranking 29th among 102 companies in the industry, while the industry leader, Shanghai Steel Union, reported a revenue of 57.318 billion yuan [2] - The company's net profit for the same period was -107 million yuan, placing it 89th in the industry, with the top performer, Desay SV, reporting a net profit of 1.805 billion yuan [2] Group 2: Financial Ratios - As of Q3 2025, Chuangye Huikang's debt-to-asset ratio was 20.27%, an increase from 19.01% year-on-year, which is lower than the industry average of 31.94%, indicating strong debt repayment capability [3] - The gross profit margin for the same period was 49.87%, slightly down from 50.14% year-on-year, but still above the industry average of 41.71%, reflecting good profitability [3] Group 3: Executive Compensation - The chairman, Zhang Lvzhen, received a salary of 1.0848 million yuan in 2024, a slight decrease from 1.0858 million yuan in 2023 [4] - The general manager, Chen Zhongyang, earned 1.4098 million yuan in 2024, significantly up from 420,400 yuan in 2023 [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 0.69% to 64,400, while the average number of circulating A-shares held per shareholder increased by 0.70% to 23,700 [5] - Major shareholders included Noan Active Return Mixed A, which held 16.108 million shares, down by 8.0292 million shares from the previous period [5] Group 5: Market Outlook - Huatai Securities noted that the decline in revenue and profit in the first three quarters of 2025 was due to short-term market pressures and the lack of scale revenue from new products, but performance is expected to recover with industry demand [5] - Zhongtai Securities adjusted its revenue forecasts for 2025-2027 to 1.468 billion, 1.592 billion, and 1.794 billion yuan, respectively, with net profits projected at 50 million, 130 million, and 216 million yuan [6]

Core Viewpoint - The stock of Chuangye Huikang (300451) has shown a recent increase in price, but the company is facing significant declines in revenue and profit margins, indicating potential challenges ahead [1][3]. Financial Performance - As of October 31, 2025, Chuangye Huikang's stock closed at 4.76 yuan, up 3.48% with a trading volume of 507,300 shares and a turnover of 239 million yuan [1]. - For the third quarter of 2025, the company reported a main revenue of 285 million yuan, a year-on-year decrease of 35.5%, and a net profit attributable to shareholders of -41.67 million yuan, down 264.2% year-on-year [3]. - The company's total revenue for the first three quarters of 2025 was 862 million yuan, a decline of 26.26% compared to the previous year, with a net profit of -122 million yuan, down 331.69% [3]. Market Position and Ratios - Chuangye Huikang's total market capitalization is 73.74 billion yuan, with a net asset value of 4.375 billion yuan [3]. - The company has a negative price-to-earnings ratio of -45.25 and a price-to-book ratio of 1.71, which is significantly lower than the industry average [3]. - The gross margin stands at 49.87%, which is above the industry average of 43.84%, but the net margin is -12.39%, indicating profitability issues [3]. Investment Sentiment - In the last 90 days, four institutions have rated the stock as a buy, with an average target price of 5.76 yuan [4]. - The recent capital flow data indicates a net outflow of 16.72 million yuan from institutional investors on October 31, 2025, while retail investors saw a net inflow of 15.28 million yuan [1][2].